Coherus BioSciences Cash from Operations (TTM) Analysis

Coherus BioSciences Inc (CHRS)

1.895 -0.22 (-10.61%) USD | NASDAQ | May 10, 16:00

1.91 +0.02 (+0.79%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	-174.88M
September 30, 2023	-261.90M
June 30, 2023	-244.69M
March 31, 2023	-255.81M
December 31, 2022	-241.12M
September 30, 2022	-193.49M
June 30, 2022	-142.69M
March 31, 2022	-92.84M
December 31, 2021	-37.43M
September 30, 2021	48.01M
June 30, 2021	81.66M
March 31, 2021	142.04M
December 31, 2020	154.14M
September 30, 2020	138.73M
June 30, 2020	146.33M
March 31, 2020	98.82M
December 31, 2019	28.36M
September 30, 2019	-36.72M
June 30, 2019	-134.46M

Date	Value
March 31, 2019	-182.66M
December 31, 2018	-159.27M
September 30, 2018	-141.82M
June 30, 2018	-140.55M
March 31, 2018	-160.59M
December 31, 2017	-200.29M
September 30, 2017	-257.26M
June 30, 2017	-277.69M
March 31, 2017	-249.51M
December 31, 2016	-252.54M
September 30, 2016	-160.09M
June 30, 2016	-157.79M
March 31, 2016	-151.24M
December 31, 2015	-107.99M
September 30, 2015	-146.84M
June 30, 2015	-92.36M
March 31, 2015	-71.73M
December 31, 2014	-23.93M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-261.90M

Minimum

Sep 2023

154.14M

Maximum

Dec 2020

-51.47M

Average

-37.43M

Median

Dec 2021

Cash from Operations (TTM) Benchmarks